Latest News about General
Recent news which mentions General
Merck's Gardasil Shot Challenges To Continue, Analysts Optimistic For Newly Approved Sotatercept For Rare Lung Disease
November 01, 2024
From Benzinga
Bristol Myers Squibb Expects New Schizophrenia Treatment To Boost Long-Term Growth, Analysts Remain Cautious
November 01, 2024
From Benzinga
Shell Reports Strong Q3: Analysts Highlight Robust Buybacks Amid Market Challenges
November 01, 2024
From Benzinga
Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst
November 01, 2024
From Benzinga
What's Going On With Rivian Stock Today?
November 01, 2024
From Benzinga
From Benzinga
Church & Dwight Surpasses Q3 Expectations: Strong Sales Growth And Brand Investments Fuel Gains
November 01, 2024
From Benzinga
Apple, Microsoft Need To Do More Than Just Beating Wall Street Estimates, Says Analyst: 'AI Enthusiasm And Potential Is Not Enough"
November 01, 2024
From Benzinga
Cancer-Focused ESSA Pharma Ends Prostate Cancer Trial Due to Insufficient Efficacy From Combination Therapy
November 01, 2024
From Benzinga
From Benzinga
From Benzinga
FDA Panel Rejects Lexicon's Zynquista For Type 1 Diabetes
November 01, 2024
From Benzinga
Analyst Throws Support Behind Intel CEO Gelsinger After Better-Than-Expected Q3 Results: 'If You're Questioning Pat As The Leader, Then Who Else?'
November 01, 2024
From Benzinga
Apple Shares Dip In Pre-Market Trading: What's Going On
November 01, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.